Sabra Health Care REIT remains a Buy, driven by its aggressive pivot into the Seniors Housing Operating Portfolio model. Read ...

When Najma Muhammad's eyes locked onto the drone footage showing an inferno tearing through the warehouse that housed her ...

If you're a retirement planner, you've probably spent plenty of time working through key decisions -- when to start tapping ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

AMN Healthcare Services has been on fire lately. In the past six months alone, the company’s stock price has rocketed 113%, setting a new 52-week high of $33.29 per share. This was partly due to its ...

ResMed is selling its MatrixCare home-health software unit to Frazier Healthcare Partners for $490m in cash to focus on sleep and breathing care.

Resmed (NYSE:RMD) announced today that it agreed to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm. Frazier Healthcare Partners agreed to pay $490 million for the ...

Pfizer's 7% yield and forward P/E of 8 complement Viatris's three FDA PDUFA decisions arriving before year-end 2026. Kimberly-Clark's pending acquisition of Kenvue at $3.50 cash plus shares gives ...

Asian shares have retreated despite a rebound for AI stocks that lifted benchmarks on Wall Street. The Kospi in South Korea ...

CRNX surges on Vertex’s $10B deal, FISV rises on STAR sale talks, RIVN drops on offering, MU slips on glut fears—read more.

NVO trades at a forward P/E of 14 and PFE at just 8x, making both the cheapest large-cap healthcare names despite strong ...

Nvidia (NVDA 0.62%) has arguably been the biggest overall winner in the AI race. The company's graphics processing units (GPUs) have been essential to training and running AI programs, making Nvidia ...